Breaking News

You are here » Indian-Commodity  :  Corporate  :  Sun Pharma reports 7% rise in Q4 consolidated net profit

26-May2018

Sun Pharma reports 7% rise in Q4 consolidated net profit

Sun Pharmaceutical Industries has reported results for the fourth quarter and year ended March 31, 2018.

The company has reported a rise of 83.30% in its net profit at Rs 176.26 crore for the quarter ended March 31, 2018 as compared to Rs 96.16 crore for the same quarter in the previous year. Total income of the company increased by 21.08% at Rs 2460.07 crore for quarter under review as compared to Rs 2031.74 crore for the quarter ended March 31, 2017.

On consolidated basis, the company has reported a rise of 6.97% in its net profit after taxes, share of profit/ (loss) of associates and joint ventures and non- controlling interests at Rs 1308.96 crore for the quarter ended March 31, 2018 as compared to Rs 1223.71 crore for the corresponding quarter in the FY17. However, total consolidated income of the company decreased by 1.11% at Rs 7279.85 crore for quarter under review as compared to Rs 7361.46 crore for the same quarter ended previous year.

For the year ended March 31, 2018, the company has posted a net loss of Rs 494.59 crore as compared to net loss of Rs 22.84 crore for the previous year. However, total income of company increased by 9.24% at Rs 9075.64 crore for year under review as compared to Rs 8308.28 crore for the year ended March 31, 2017.

For the year ended March 31, 2018, on the consolidated basis, the company has posted a fall of 68.96% in its net profit after taxes, share of profit/ (loss) of associates and joint ventures and non- controlling interests at Rs 2161.55 crore as compared to Rs 6964.37 crore for the same period in the previous year. Total income of company decreased by 15.13% at Rs 27328.22 crore for year under review as compared to Rs 32201.59 crore for the year ended March 31, 2017.


Related News

View all news

NCLT levies penalty on Tata Chemicals

The National Company Law Tribunal (NCLT) Mumbai, has levied a penalty of Rs 10 lakh on Tata Chemicals for filing a petition fraudulently and with malicious intent to liquidate Raj Process Equipment and......

Reliance Industries' arms to launch new e-commerce platform

Reliance Industries' group companies--Reliance Jio and Retail will launch a new e-commerce platform in the country. This project will empower 12 lakh small retailers in Gujarat.Reliance Industries is India's......

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......